The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Thyroid Gland Disorders Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to the thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When the thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, the body metabolism and functioning will be disrupted.
The global Thyroid Gland Disorders Treatment market size is expected to reach US$ 3871.9 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Thyroid Gland Disorders Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Other, are propelling Thyroid Gland Disorders Treatment market. Hypothyroidism, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hyperthyroidism segment is estimated at % CAGR for the next seven-year period.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thyroid Gland Disorders Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thyroid Gland Disorders Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thyroid Gland Disorders Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thyroid Gland Disorders Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thyroid Gland Disorders Treatment covered in this report include AbbVie, Merck KGaA, Lannett Company, Mylan, Allergan, Pfizer, Novartis, GlaxoSmithKline and Abbott Laboratories, etc.
The global Thyroid Gland Disorders Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Merck KGaA
Lannett Company
Mylan
Allergan
Pfizer
Novartis
GlaxoSmithKline
Abbott Laboratories
Sanofi
Global Thyroid Gland Disorders Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thyroid Gland Disorders Treatment market, Segment by Type:
Hypothyroidism
Hyperthyroidism
Global Thyroid Gland Disorders Treatment market, by Application
Hospitals
Clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Thyroid Gland Disorders Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to the thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When the thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, the body metabolism and functioning will be disrupted.
The global Thyroid Gland Disorders Treatment market size is expected to reach US$ 3871.9 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Thyroid Gland Disorders Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Other, are propelling Thyroid Gland Disorders Treatment market. Hypothyroidism, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hyperthyroidism segment is estimated at % CAGR for the next seven-year period.
North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thyroid Gland Disorders Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thyroid Gland Disorders Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thyroid Gland Disorders Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thyroid Gland Disorders Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thyroid Gland Disorders Treatment covered in this report include AbbVie, Merck KGaA, Lannett Company, Mylan, Allergan, Pfizer, Novartis, GlaxoSmithKline and Abbott Laboratories, etc.
The global Thyroid Gland Disorders Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Merck KGaA
Lannett Company
Mylan
Allergan
Pfizer
Novartis
GlaxoSmithKline
Abbott Laboratories
Sanofi
Global Thyroid Gland Disorders Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thyroid Gland Disorders Treatment market, Segment by Type:
Hypothyroidism
Hyperthyroidism
Global Thyroid Gland Disorders Treatment market, by Application
Hospitals
Clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Thyroid Gland Disorders Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Thyroid Gland Disorders Treatment
1.1 Thyroid Gland Disorders Treatment Market Overview
1.1.1 Thyroid Gland Disorders Treatment Product Scope
1.1.2 Thyroid Gland Disorders Treatment Market Status and Outlook
1.2 Global Thyroid Gland Disorders Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Thyroid Gland Disorders Treatment Market Size by Region (2018-2029)
1.4 Global Thyroid Gland Disorders Treatment Historic Market Size by Region (2018-2023)
1.5 Global Thyroid Gland Disorders Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Thyroid Gland Disorders Treatment Market Size (2018-2029)
1.6.1 North America Thyroid Gland Disorders Treatment Market Size (2018-2029)
1.6.2 Europe Thyroid Gland Disorders Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Thyroid Gland Disorders Treatment Market Size (2018-2029)
1.6.4 Latin America Thyroid Gland Disorders Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Thyroid Gland Disorders Treatment Market Size (2018-2029)
2 Thyroid Gland Disorders Treatment Market by Type
2.1 Introduction
2.1.1 Hypothyroidism
2.1.2 Hyperthyroidism
2.2 Global Thyroid Gland Disorders Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Thyroid Gland Disorders Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Thyroid Gland Disorders Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Thyroid Gland Disorders Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Thyroid Gland Disorders Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Thyroid Gland Disorders Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Thyroid Gland Disorders Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Thyroid Gland Disorders Treatment Revenue Breakdown by Type (2018-2029)
3 Thyroid Gland Disorders Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Other
3.2 Global Thyroid Gland Disorders Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Thyroid Gland Disorders Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Thyroid Gland Disorders Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Thyroid Gland Disorders Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Thyroid Gland Disorders Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Thyroid Gland Disorders Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Thyroid Gland Disorders Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Thyroid Gland Disorders Treatment Revenue Breakdown by Application (2018-2029)
4 Thyroid Gland Disorders Treatment Competition Analysis by Players
4.1 Global Thyroid Gland Disorders Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thyroid Gland Disorders Treatment as of 2022)
4.3 Date of Key Players Enter into Thyroid Gland Disorders Treatment Market
4.4 Global Top Players Thyroid Gland Disorders Treatment Headquarters and Area Served
4.5 Key Players Thyroid Gland Disorders Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Thyroid Gland Disorders Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Thyroid Gland Disorders Treatment Products, Services and Solutions
5.1.4 AbbVie Thyroid Gland Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 AbbVie Recent Developments
5.2 Merck KGaA
5.2.1 Merck KGaA Profile
5.2.2 Merck KGaA Main Business
5.2.3 Merck KGaA Thyroid Gland Disorders Treatment Products, Services and Solutions
5.2.4 Merck KGaA Thyroid Gland Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Merck KGaA Recent Developments
5.3 Lannett Company
5.3.1 Lannett Company Profile
5.3.2 Lannett Company Main Business
5.3.3 Lannett Company Thyroid Gland Disorders Treatment Products, Services and Solutions
5.3.4 Lannett Company Thyroid Gland Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Mylan Recent Developments
5.4 Mylan
5.4.1 Mylan Profile
5.4.2 Mylan Main Business
5.4.3 Mylan Thyroid Gland Disorders Treatment Products, Services and Solutions
5.4.4 Mylan Thyroid Gland Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Mylan Recent Developments
5.5 Allergan
5.5.1 Allergan Profile
5.5.2 Allergan Main Business
5.5.3 Allergan Thyroid Gland Disorders Treatment Products, Services and Solutions
5.5.4 Allergan Thyroid Gland Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Allergan Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Thyroid Gland Disorders Treatment Products, Services and Solutions
5.6.4 Pfizer Thyroid Gland Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Pfizer Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Thyroid Gland Disorders Treatment Products, Services and Solutions
5.7.4 Novartis Thyroid Gland Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 GlaxoSmithKline
5.8.1 GlaxoSmithKline Profile
5.8.2 GlaxoSmithKline Main Business
5.8.3 GlaxoSmithKline Thyroid Gland Disorders Treatment Products, Services and Solutions
5.8.4 GlaxoSmithKline Thyroid Gland Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 GlaxoSmithKline Recent Developments
5.9 Abbott Laboratories
5.9.1 Abbott Laboratories Profile
5.9.2 Abbott Laboratories Main Business
5.9.3 Abbott Laboratories Thyroid Gland Disorders Treatment Products, Services and Solutions
5.9.4 Abbott Laboratories Thyroid Gland Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Abbott Laboratories Recent Developments
5.10 Sanofi
5.10.1 Sanofi Profile
5.10.2 Sanofi Main Business
5.10.3 Sanofi Thyroid Gland Disorders Treatment Products, Services and Solutions
5.10.4 Sanofi Thyroid Gland Disorders Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Sanofi Recent Developments
6 North America
6.1 North America Thyroid Gland Disorders Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Thyroid Gland Disorders Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Gland Disorders Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Thyroid Gland Disorders Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Gland Disorders Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Thyroid Gland Disorders Treatment Market Dynamics
11.1 Thyroid Gland Disorders Treatment Industry Trends
11.2 Thyroid Gland Disorders Treatment Market Drivers
11.3 Thyroid Gland Disorders Treatment Market Challenges
11.4 Thyroid Gland Disorders Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
